Tumor cell growth is inhibited by suppressing metallothionein-I synthesis

Cancer Letters

Volumn 116, Issue 2, 1997, Pages 145-149

  Takeda, Atsushi ^a   Hisada, Harumi ^a   Okada, Shoji ^a   Mata, John E ^b   Ebadi, Manuchair ^b   Iversen, Patric L ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antisense oligodeoxynucleotide; Metallothionein; Tumor; Zinc

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; METALLOTHIONEIN; ZINC;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; EHRLICH ASCITES TUMOR; LEUKEMIA P 388; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SARCOMA 180; TUMOR CELL LINE; TUMOR GROWTH;

ANIMALS; CELL DIVISION; LEUKEMIA P388; METALLOTHIONEIN; MICE; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDES, ANTISENSE; TUMOR CELLS, CULTURED; ZINC;

EID: 0030833611     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00172-9     Document Type: Article

References (32)

1. Margoshes M., Vallee B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 79:1957;4813-4814.
2. Hamer D.H. Metallothionein. Annu. Rev. Biochem. 55:1986;913-951.
3. Bremner, I. and Beattie, J.H. (1990) Metallothionein and the trace metal. Annu. Rev. Nutr., 10.
4. Suzuki, K.T., Imura, N. and Kimura, M. (1993) Metallothionein III: Biological Roles and Medical Implications. Birkhauser, Basel.
5. Durman D.M., Palmiter R.D. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J. Biol. Chem. 256:1981;5712-5716.
6. Mayo K.E., Palmiter R.D. Glucocorticoid regulation of the mouse metallothionein-I mRNA synthesis in cultured mouse cells. J. Biol. Chem. 256:1981;2621-2624.
7. Brady F.O. Induction of metallothionein in rats. Methods Enzymol. 205:1991;559-567.
8. Nishimura H., Nishimura N., Tohyama C. Immunohistochemical localization of metallothionein in developing rat tissues. J. Histochem. Cytochem. 37:1989;715-722.
9. Elmes M.E., Haywood S., Jasani B. A histochemical and immunocytochemical study of hepatic copper and metallothionein in the pre- and post-natal rat. J. Pathol. 164:1991;83-87.
10. Searle P.F., Davison B.L., Stuart G.W., Wilkie T.M., Norstedt G., Palmiter R.D. Regulation, linkage and sequence of mouse metallothionein I and II genes. Mol. Cell Biol. 4:1984;1221-1230.
11. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA. 89:1992;6333-6337.
12. Prohaska J.R. Functions of trace elements in brain metabolism. Physiol. Rev. 67:1987;858-901.
13. Ebadi M., Swanson S. The status of zinc, copper and metallothionein in cancer patients. Prog. Clin. Biol. Res. 259:1988;161-167.
14. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73:1993;79-118.
15. Iversen P.L., Ebadi E. Antisense oligonucleotide-mediated inhibition of metallothionein protein synthesis in neuroblastoma IMR32 and Chang liver cells in culture. Biol. Signals. 1:1992;57-64.
16. Iversen P.L., Mata J.E., Ebadi M. Synthetic antisense oligonucleotide probes the essentiality of metallothionein gene. Biol. Signals. 1:1992;293-299.
17. Takeda A., Norris J.S., Iversen P.L., Ebadi M. Antisense oligonucleotide of c-myc discriminates between zinc- and dexamethasone-induced synthesis of metallothionein. Pharmacology. 48:1994;119-126.
18. Cohen, J.S. (1990) Antisense oligonucleotides as an approach towards anti-AIDS therapy. In: Design of Anti-AIDS Drug, Vol. 14, pp. 195-256. Editor: E. Declerq. Elsevier, New York.
19. Bacon T.A., Wickstrom E. Walking along human c-myc mRNA with antisense oligonucleotides: maximum efficacy at the 5' cap region. Oncogene Res. 6:1991;13-19.
20. Page B., Page M., Noel C. A new fluorometric assay for cytotoxicity measurements in vitro. Int. J. Oncol. 3:1993;473-476.
21. Aoki Y., Suzuki K.T. Detection of metallothionein by western blotting. Methods Enzymol. 205:1991;108-114.
22. Takeda A., Tamano H., Hoshino A., Okada S. Elevation of hepatic levels of metallothionein during experimental carcinogenesis. Biol. Trace Elem. Res. 41:1994;157-164.
23. Tsujikawa K., Suzuki N., Sagawa K., Itoh M., Sugiyama T., Kohama Y., Otaki N., Kimura M., Kimura T. Induction and subcellular localization of metallothionein in regenerating rat liver. Eur. J. Cell. Biol. 63:1994;240-246.
24. Woo E.S., Kondo Y., Watkins S.C., Hoyt D.G., Lazo J.S. Nucleophilic distribution of metallothionein in human tumor cells. Exp. Cell Res. 224:1996;365-371.
25. Masters B.A., Kelly E.J., Quaife C.J., Brinster R.L., Palmiter R.D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA. 91:1994;584-588.
26. Krezoski S.K., Villalobos J., Shaw III C.F., Petering D.H. Kinetic lability of zinc bound to metallothionein in Ehrlich cells. Biochem. J. 255:1988;483-491.
27. Mayo K.E., Palmiter R.D. Glucocorticoid regulation of metallothionein-I mRNA synthesis in cultured mouse cells. J. Biol. Chem. 256:1981;2621-2624.
28. Zalewski P.D., Forbes I.J., Betts W.H. Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem. J. 296:1993;403-408.
29. McCabe M.J. Jr., Jiang S.A., Orrenivs S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 69:1993;101-110.
30. Satoh M., Kloth D.M., Kadhim S.A., Chin J.L., Naganuma A., Imura N., Cherian M.G. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res. 53:1993;1829-1832.
31. Satoh M., Cherian M.G., Imura N., Shimizu H. Modulation of resistance to anticancer drugs by inhibition by metallothionein synthesis. Cancer Res. 54:1994;5255-5257.
32. Kondo Y., Kuo S.-M., Watkins S.C., Lazo J.S. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res. 55:1995;474-477.